Volume might seem small, but the last 10 trading days in April last year RBT averaged 16,800 shares. This and Continental Grain already buying 2,700,000 shares in September 2017 and 1,100,000 shares in the previous month of March. In the last 10 trading days not counting today, the daily average has been 47,400 shares. Not counting today, the stock has risen from $2.90 to $3.16, or just over 9%, the last 10 day of April the stock went from $1.60 to $1.56. Dullness in a bull market is bullish. Volume the last two weeks even though much bigger than the last 1/2 of April is still way below the recent average listed at Yahoo Finance of 106,000 shares.
Any positive news and this stock rockets. Possibilities?
1. Rystrom puts up upgraded guidance. Heck we go over 4 months between CC's. Much SHOULD change in 4 months, don't ya think? 2. A new big customer 3. I take the 2 recent presentations at the ICR Conference and the Lake Street Capital "Best Idea's Growth Conference" as looking for capital to expand. Hey, CG already has a division in China. Heck, our product would fight right in, even if it's just the horse feed. SRB would fit right in NOW NOW NOW. With 10m in cash the last CC and cash flow positive less than 6 months away, they do NOT need cash now, unless for major expansion.
Yahoo shows it 7.08, but Yahoo is yet factoring in the sales we get from Golden Ridge. If I take Rystrom's low 2019 forecast of $40,000,000 and figure in 32,000,000 shares by then, 1.25 X today's price of $3.22 and P/S will be an years end--- 2.57.
OK, it varies by industry and potential. Below are some price/sales examples.
ADM - .38-- low margin industry GIS- - 1.60 bigger margins in manufacturing food products AMZN - 3.53 - 20% revenue growth this coming quarter FUSZ - 2,975- Interactive video technology(gaming), developmental company, big sales expected GLMD- 67.05 Pharma, new products coming
The above is just a small sampling. I base RIBT's P/S at the end of 2019, the others current. Yes the others can change during the year so not an exact comparison. BTW, I don't think Rystrom told us what Golden Ridge was going to do sales wise in 2018. That makes it hard to see the affect RIBT will have there, would be nice to know.
My point, RIBT's year end P/S at 2.57 Looks really low compared to AMZN to me. RIBT with it's rice bran protein has a much easier chance of doubling revenue in 2020 than AMZN, IMO. I feel RIBT is a cross between GLMD and AMZN. If RIBT's price/sales was 3 times higher than now, I'd call it fair. So, that is a $9.66 stock, with what we know now. Get some speculators in and even higher.
The problem is the street does not even know about Golden Ridge, when they look at the Yahoo statistics. They don't know about rice bran potential and the potential, especially the SRB protein is like a pharma product to me, maybe not a blockbuster pharma product, but a good one.
When the Year End CC happens in mid March, any good news and RIBT is a $5.00+ stock. One potential positive unknown is why Rystrom wants the $4,000,000 from the $3.25 warrants that expire in mid April. hmmmmm.
Of course, any good news before the CC gives us a $5.00 stock, IMO.
Market Data 
Markets 
AI
